Definitive Contract HHSO100201300017C
Award Date 7/15/13
Potential Completion Date 7/28/18
Potential Value $45M
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Madison, WI 53719, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,730,436.20 firm-fixed price contract awarded by the U.S. Army Medical Command (MEDCOM) to Stratatech Corporation, a subsidiary of Mallinckrodt Plc, for a Phase 2 clinical trial to evaluate the safety and efficacy of an allogeneic skin substitute product called STRATAGRAFT. STRATAGRAFT contains both an epidermal and dermal layer and is intended for the treatment of complex, full-thickness skin injuries. The contract has an ultimate completion date of October 31, 2019 and was...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Stratatech Corporation, a subsidiary of Mallinckrodt Plc, a global pharmaceutical company. The $178,327 Firm Fixed Price contract is for the development of a "3D Skin Model with Enhanced Sensitivity and Throughput", which is likely an advanced tissue engineering or regenerative medicine project. Stratatech Corporation has...
- <p>The U.S. Defense Health Agency awarded a $23,204.00 firm fixed price purchase order contract to Lifecell Corporation, a division of Allergan, Inc., for the delivery of STRATTICE - 20 X 25 products. The contract has an ultimate completion date of June 6, 2016 and was awarded on May 27, 2016. This contract award was not associated with a set-aside program.</p>
- This federal contract award was made by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The contract, with a ceiling value of $78,582.00, is for the procurement of 2540002-STRATTICE 25 X 40CM products. The contract type is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing structure. The place of performance is Bethesda, MD. The contract has no set-aside designation and the ultimate completion date is June 14, 2016.
- <p>The U.S. Department of the Navy's Bureau of Medicine and Surgery awarded a Firm Fixed Price purchase order contract to LifeCell Corporation, a division of Allergan, Inc., for the delivery of STRATTICE RECONSTRUCTIVE TISSUE. The contract has a ceiling value of $3,574.00 and a completion date of May 20, 2015. The contract was not set aside for any particular business type. No additional details about a larger vehicle or major subcontractors were provided.</p>
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation, a foreign-owned, for-profit manufacturer of human tissue models. The $187,370.03 award is for providing human alveolar and tracheobronchial tissues to support viral infection/disease modeling and antiviral discovery research for SARS-CoV-2. The original solicitation was a non-competitive,...
- This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
- This is a $1,239.95 fixed-price delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of the APLIGRAF skin substitute product, which is used for advanced wound care. Organogenesis is a key supplier of medical products to federal healthcare agencies, including the Department of Veterans Affairs (VA) and the DLA, and has several significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
- This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...